1 00:00:02,520 --> 00:00:09,960 Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers Report, 2 00:00:10,280 --> 00:00:13,440 Speaker 1: your roundup of companies making moves in the stock market, 3 00:00:13,680 --> 00:00:15,880 Speaker 1: harnessing the power of Bloomberg Data. 4 00:00:16,600 --> 00:00:18,400 Speaker 2: Let's take a look at some of the stocks on 5 00:00:18,560 --> 00:00:20,880 Speaker 2: the move today. I'm Paul swinging alongside Lis Mittel. I'm 6 00:00:20,960 --> 00:00:23,520 Speaker 2: joined by Bloomberg's Tatiana Daria Tatiana. What are you looking 7 00:00:23,520 --> 00:00:27,200 Speaker 2: at today? Well, starting off with Novo Nordisk, which is 8 00:00:27,520 --> 00:00:30,760 Speaker 2: ADRs are up about a four percent. Your tickers and 9 00:00:31,000 --> 00:00:33,479 Speaker 2: vo and I know you guys just discussed the story. 10 00:00:33,520 --> 00:00:36,720 Speaker 2: But what is interesting to me is that it all 11 00:00:36,760 --> 00:00:39,880 Speaker 2: comes after President Trump has been putting pressure on farmat 12 00:00:39,920 --> 00:00:43,080 Speaker 2: companies to lower drug costs. So the company slash the 13 00:00:43,120 --> 00:00:46,440 Speaker 2: cost of ozempic for cash bank patients to four ninety 14 00:00:46,520 --> 00:00:49,559 Speaker 2: nine a month, about half of its US list pricing 15 00:00:49,600 --> 00:00:54,360 Speaker 2: that this move really caters to patients who don't have insurance. 16 00:00:54,520 --> 00:00:58,120 Speaker 2: So it looks like maybe companies are trying to work 17 00:00:58,160 --> 00:01:01,480 Speaker 2: with the president here to avoid more public shaming, because 18 00:01:01,560 --> 00:01:04,280 Speaker 2: Eli Lilly also last week raised the list price for 19 00:01:04,360 --> 00:01:07,080 Speaker 2: its abusity shot shot in the UK by as much 20 00:01:07,120 --> 00:01:11,000 Speaker 2: as one hundred and seventy percent, as President Trump also 21 00:01:11,040 --> 00:01:14,360 Speaker 2: asked companies to increase prices in Europe and to lower 22 00:01:14,400 --> 00:01:17,440 Speaker 2: them for Americans. Well, for the record, Novo said that 23 00:01:17,480 --> 00:01:21,319 Speaker 2: the offer is unrelated to discussions with the US government. 24 00:01:21,680 --> 00:01:24,360 Speaker 2: And it's also worth noting that the stock was rallying 25 00:01:24,360 --> 00:01:26,920 Speaker 2: there a little bit even before the news as we go, 26 00:01:27,120 --> 00:01:30,880 Speaker 2: VI received the FDA approval to treat a serious form 27 00:01:30,959 --> 00:01:33,240 Speaker 2: of liver disease. So it looks like there is different 28 00:01:33,240 --> 00:01:36,160 Speaker 2: parts here, but it's interesting to follow sort of that 29 00:01:37,440 --> 00:01:41,640 Speaker 2: the government or Trump's push to load drug pricing and 30 00:01:41,680 --> 00:01:44,440 Speaker 2: if that is really having an impact already, and then 31 00:01:44,440 --> 00:01:48,880 Speaker 2: good rex is this tied into Novo Nordics definitely tied 32 00:01:48,920 --> 00:01:51,480 Speaker 2: to this story. You know the company and the stock 33 00:01:51,600 --> 00:01:54,240 Speaker 2: is up thirty three percent right now. The ticker is 34 00:01:54,480 --> 00:01:58,000 Speaker 2: gd r X. The CEO and Bloomberg TV making the 35 00:01:58,040 --> 00:02:00,880 Speaker 2: case for the company this morning, explain really how this 36 00:02:01,000 --> 00:02:04,240 Speaker 2: company works, because a lot of people had questions, and 37 00:02:04,480 --> 00:02:07,880 Speaker 2: it says that it's a digital marketplace for drugs pricing. 38 00:02:08,240 --> 00:02:11,960 Speaker 2: It really doesn't fulfill or dispense the drugs, but it 39 00:02:12,040 --> 00:02:16,600 Speaker 2: negotiates the most competitive prices with insurance and analysts are 40 00:02:16,600 --> 00:02:19,360 Speaker 2: saying that this deal with Nova Nordisk will allow the 41 00:02:19,400 --> 00:02:25,160 Speaker 2: company to monetize about seventeen million patients looking for GLP ones, 42 00:02:25,280 --> 00:02:29,480 Speaker 2: So huge opportunity there for them. Right. What else, well, 43 00:02:29,560 --> 00:02:33,680 Speaker 2: staying with the pharma space, looking at cbs UBS upgrading 44 00:02:33,800 --> 00:02:37,360 Speaker 2: the stock here ticker is see the as up about 45 00:02:37,400 --> 00:02:41,320 Speaker 2: three percent, the analyst writing that the upgrade follows two 46 00:02:41,320 --> 00:02:44,840 Speaker 2: strong consecutive quarters and early sign that the healthcare benefits 47 00:02:44,840 --> 00:02:48,160 Speaker 2: segment fixes are on track. As a reminder, the company 48 00:02:48,240 --> 00:02:53,280 Speaker 2: is exiting the Obamacare individual health insurance exchange market next year, 49 00:02:53,320 --> 00:02:57,279 Speaker 2: and it is focusing on higher margin segments like Medicare advantage, 50 00:02:57,520 --> 00:03:01,640 Speaker 2: and it looks like that is really catching analysts attention 51 00:03:01,800 --> 00:03:05,160 Speaker 2: because this upgrade comes after a similar boost from Baird 52 00:03:05,280 --> 00:03:09,320 Speaker 2: on Friday. The stock now has twenty three buys, six holds, 53 00:03:09,360 --> 00:03:13,000 Speaker 2: and no sales poll and the average price target is 54 00:03:13,080 --> 00:03:16,560 Speaker 2: eighty one dollars, signaling analysts sea growth potential because we're 55 00:03:16,600 --> 00:03:19,760 Speaker 2: trading at seventy dollars and sixty six cents right now. 56 00:03:20,960 --> 00:03:25,000 Speaker 1: The Stock Movers report from Bloomberg Radio. Check back with 57 00:03:25,080 --> 00:03:27,639 Speaker 1: us throughout the day for the latest roundup of companies 58 00:03:27,720 --> 00:03:30,840 Speaker 1: making news on Wall Street and for the latest market 59 00:03:30,840 --> 00:03:35,320 Speaker 1: moving headlines. Listen to Bloomberg Radio Live. Catch us on YouTube, 60 00:03:35,400 --> 00:03:38,920 Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with 61 00:03:38,960 --> 00:03:40,480 Speaker 1: the Bloomberg Business app.